SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Policies and Incentives for Promoting Innovation in Antibiotic Research
16 references·1 citing·46 second hop
Policies and Incentives for Promoting Innovation in Antibiotic Research (2010)Policies and Incentives for Promoting Inn…Demand-pull, technology-push, and government-led incentives for non-incremental technical change (2009)Demand-pull, technology-push,…Market incentives and pharmaceutical innovation (2008)Market incentives and pharmac…Seven habits of highly effective global public–private health partnerships: Practice and potential (2006)Seven habits of highly effect…Developing Drugs For Developing Countries (2006)Developing Drugs For Developi…Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases (2005)Strong Medicine: Creating Inc…Productivity in pharmaceutical–biotechnology R&D: the role of experience and alliances (2005)Productivity in pharmaceutica…A Breakthrough in R&D for Neglected Diseases: New Ways to Get the Drugs We Need (2005)A Breakthrough in R&D for Neg…Static and Dynamic Effects of Health Policy: Evidence from the Vaccine Industry (2004)Static and Dynamic Effects of…Patents and R&D as Real Options (2004)Patents and R&D as Real Optio…Why is big Pharma getting out of antibacterial drug discovery? (2003)Why is big Pharma getting out…The price of innovation: new estimates of drug development costs (2003)The price of innovation: new …Rewards versus Intellectual Property Rights (2001)Rewards versus Intellectual P…Patent Buy-Outs: A Mechanism for Encouraging Innovation (1997)Patent Buy-Outs: A Mechanism …Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry (1991)Patent Expiration, Entry, and…Networks of innovators :A review and introduction to the issue (1991)Networks of innovators :A rev…The Demand for Health: A Theoretical and Empirical Investigation (1975)The Demand for Health: A Theo…Research and development of antibiotics: insights from patents and citation network (2016)Research and development of a…The Strength of Weak Ties (1973)Perspectives on Technology (1977)Networks of Power: Electrification in Western Society, 1880-1930 (1984)Networks of innovators: A synthesis of research issues (1991)Local Geographic Spillovers between University Research and High Technology Innovations (1997)Models of technology diffusion (2000)A Contribution to the Theory of Economic Growth (1956)Absorptive Capacity: A New Perspective on Learning and Innovation (1990)Capitalism, Socialism and Democracy (1997)Environmental Policy and Directed Technological Change: Evidence from the European Carbon Market (2014)The open eco-innovation mode. An empirical investigation of eleven European countries (2014)Exploring the impact of digital transformation on technology entrepreneurship and technological market expansion: The role of technology readiness, exploration and exploitation (2020)Global public-private partnerships: Part I--A new development in health? (2000)Global health funding: how much, where it comes from and where it goes (2009)Transnational Public-Private Partnerships in International Relations: Making Sense of Concepts, Research Frameworks, and Results (2009)The GAVI Alliance and the ‘Gates approach’ to health system strengthening (2014)Invention and Economic Growth (1966)Pharmaceutical Price Controls and Entry Strategies (2007)Do Firms Underinvest in Long-Term Research? Evidence from Cancer Clinical Trials (2015)In the Shadow of a Giant: Medicare’s Influence on Private Physician Payments (2016)American Economic Review (2019)The Quarterly Journal of Economics (2024)Imitation Costs and Patents: An Empirical Study (1981)Do Scientists Pay to Be Scientists? (2004)When Does University Research Get Commercialized? Creating Ambidexterity in Research Institutions (2008)Global Warming Gridlock (2011)Industrial Market Structure and Economic Performance. (1971)The Theory of Industrial Organization (1988)Theory of Industrial Organization. (1989)Sequential Innovation, Patents, and Imitation (2000)Intellectual Property: The Law and Economics Approach (2005)Patent systems for encouraging innovation: Lessons from economic analysis (2006)Free Entry and Social Inefficiency (1986)Estimation of a Model of Entry in the Airline Industry (1992)Automobile Prices in Market Equilibrium (1995)Generic Entry and the Pricing of Pharmaceuticals (1997)Generic Drug Industry Dynamics (2005)A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics (2015)Exploring different approaches to improve the success of drug discovery and development projects: a review (2020)Why big pharma has abandoned antibiotics (2020)Can the pharmaceutical industry reduce attrition rates? (2004)Clinical development success rates for investigational drugs (2014)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Chapter 7 The human capital model (2000)Poverty and health sector inequalities. (2002)The Relationship Between Education and Adult Mortality in the United States (2004)
this work references cited by second hop

References

  • 2003The price of innovation: new estimates of drug development costs4,264 cited
  • 1975The Demand for Health: A Theoretical and Empirical Investigation1,091 cited
  • 2009Demand-pull, technology-push, and government-led incentives for non-incremental technical change779 cited
  • 1991Networks of innovators :A review and introduction to the issue631 cited
  • 2003Why is big Pharma getting out of antibacterial drug discovery?503 cited
  • 1997Patent Buy-Outs: A Mechanism for Encouraging Innovation492 cited
  • 1991Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry399 cited
  • 2006Seven habits of highly effective global public–private health partnerships: Practice and potential348 cited
  • 2004Static and Dynamic Effects of Health Policy: Evidence from the Vaccine Industry323 cited
  • 2001Rewards versus Intellectual Property Rights309 cited
  • 2005Productivity in pharmaceutical–biotechnology R&D: the role of experience and alliances290 cited
  • 2005Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases237 cited
  • 2004Patents and R&D as Real Options205 cited
  • 2006Developing Drugs For Developing Countries198 cited
  • 2005A Breakthrough in R&D for Neglected Diseases: New Ways to Get the Drugs We Need

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

197 cited
  • 2008Market incentives and pharmaceutical innovation189 cited
  • Cited by

    • 2016Research and development of antibiotics: insights from patents and citation network8 cited